G.M. Breweries Limited (NSE:GMBREW)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-	1,290	1,515	998.65	933.56	800.91
Depreciation & Amortization	-	51.84	61.34	57.83	60.63	54.8
Other Amortization	-	-	-	0.31	-	0.01
Other Operating Activities	-	-476.02	-792.71	-201.8	-283.74	-282.58
Change in Accounts Receivable	-	-9.1	-14.92	28	-21.79	0.42
Change in Inventory	-	-41.46	79.33	-48.04	-39.24	-74.02
Change in Accounts Payable	-	-18.01	121.06	60.82	-2.77	-79.89
Change in Other Net Operating Assets	-	819.13	-376.63	64.61	328.05	-405.55
Operating Cash Flow	-	1,617	592.68	960.38	974.69	14.11
Operating Cash Flow Growth	-	172.79%	-38.29%	-1.47%	6808.26%	-98.21%
Sale of Property, Plant & Equipment	-	62.22	42.11	121.64	47.49	106.07
Sale (Purchase) of Real Estate	-	-518.64	-568.81	-487.27	-30.93	164.93
Investment in Securities	-	-1,511	-761.55	-706.85	-1,252	-472.92
Other Investing Activities	-	481.02	803.33	204.68	285.83	302.89
Investing Cash Flow	-	-1,486	-484.91	-867.8	-949.18	100.97
Common Dividends Paid	-	-127.94	-109.67	-91.39	-73.11	-54.83
Other Financing Activities	-	-5.75	-3.72	-0.38	-0.14	-0.63
Financing Cash Flow	-	-133.7	-113.38	-91.77	-73.25	-55.47
Net Cash Flow	-	-2.89	-5.61	0.81	-47.74	59.61
Free Cash Flow	-	1,617	592.68	960.38	974.69	14.11
Free Cash Flow Growth	-	172.79%	-38.29%	-1.47%	6808.26%	-98.21%
Free Cash Flow Margin	-	11.07%	4.21%	7.07%	9.36%	0.20%
Free Cash Flow Per Share	-	70.77	25.94	42.03	42.66	0.62
Cash Interest Paid	-	5.67	3.58	-	-	0.5
Cash Income Tax Paid	-	310	290	315	245	180
Levered Free Cash Flow	-	1,059	535.67	971.36	639.93	167.38
Unlevered Free Cash Flow	-	1,063	537.91	971.36	639.93	167.7
Change in Net Working Capital	-	-308.43	156.25	-218.31	-20.04	323.57

Updated Jan 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.